Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CLIGFOTCMKTS:HOWWYOTCMKTS:RPCGFOTCMKTS:SLFPY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLIGFClinigen Group$8.02$8.02$8.02▼$11.56$1.07B0.498,620 shsN/AHOWWYHOPEWELL HOLDIN/ADR$4.80-0.4%$4.80$2.98▼$5.10$4.17B0.2559,119 shs2,500 shsRPCGFRPC Group$10.40$10.40$8.45▼$10.85$4.24B0.211,775 shsN/ASLFPYabrdn$10.68$8.33$6.36▼$11.09$4.91B1.46806 shsN/A7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLIGFClinigen Group0.00%0.00%0.00%0.00%0.00%HOWWYHOPEWELL HOLDIN/ADR0.00%0.00%0.00%0.00%0.00%RPCGFRPC Group0.00%0.00%0.00%0.00%0.00%SLFPYabrdn0.00%+7.34%+26.39%+18.01%+39.70%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLIGFClinigen GroupN/AN/AN/AN/AN/AN/AN/AN/AHOWWYHOPEWELL HOLDIN/ADRN/AN/AN/AN/AN/AN/AN/AN/ARPCGFRPC GroupN/AN/AN/AN/AN/AN/AN/AN/ASLFPYabrdnN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLIGFClinigen Group 0.00N/AN/AN/AHOWWYHOPEWELL HOLDIN/ADR 0.00N/AN/AN/ARPCGFRPC Group 0.00N/AN/AN/ASLFPYabrdn 1.50ReduceN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLIGFClinigen Group$704.71M1.51$1.43 per share5.60$4.52 per share1.77HOWWYHOPEWELL HOLDIN/ADR$253.58M16.46$0.20 per share24.02$7.76 per share0.62RPCGFRPC Group$4.97B0.85$1.67 per share6.23$6.25 per share1.66SLFPYabrdn$1.74B2.83$0.99 per share10.83$13.76 per share0.78Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLIGFClinigen Group$40.78MN/A0.00∞N/AN/AN/AN/AN/AHOWWYHOPEWELL HOLDIN/ADR$1.15BN/A0.00∞N/AN/AN/AN/AN/ARPCGFRPC Group$336.18MN/A0.00∞N/AN/AN/AN/AN/ASLFPYabrdn$1.24MN/A0.00∞N/AN/AN/AN/A7/30/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLIGFClinigen GroupN/AN/AN/AN/AN/AHOWWYHOPEWELL HOLDIN/ADR$0.122.50%N/AN/AN/ARPCGFRPC GroupN/AN/AN/AN/AN/ASLFPYabrdn$0.656.09%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLIGFClinigen GroupN/AN/AN/AHOWWYHOPEWELL HOLDIN/ADR0.0315.6915.69RPCGFRPC GroupN/AN/AN/ASLFPYabrdn0.121.66N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLIGFClinigen GroupN/AHOWWYHOPEWELL HOLDIN/ADRN/ARPCGFRPC GroupN/ASLFPYabrdnN/AInsider OwnershipCompanyInsider OwnershipCLIGFClinigen GroupN/AHOWWYHOPEWELL HOLDIN/ADRN/ARPCGFRPC GroupN/ASLFPYabrdnN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLIGFClinigen Group1,069133.03 millionN/ANot OptionableHOWWYHOPEWELL HOLDIN/ADR1,052869.84 millionN/ANot OptionableRPCGFRPC Group24,868407.39 millionN/ANot OptionableSLFPYabrdn4,719460.19 millionN/ANot OptionableCLIGF, RPCGF, HOWWY, and SLFPY HeadlinesRecent News About These Companiesabrdn (OTCMKTS:SLFPY) Sets New 1-Year High - Should You Buy?June 10 at 5:54 PM | marketbeat.comabrdn (OTCMKTS:SLFPY) Hits New 52-Week High - Still a Buy?May 31, 2025 | marketbeat.comAbrdn to bring back vowels after disastrous rebrandMarch 4, 2025 | finance.yahoo.comThis is the extraordinary amount of passive income investors could make from £11,000 of shares in this FTSE ultra-high-yield gem…February 27, 2025 | msn.comUp 10% in a month! Is the abrdn share price set for the biggest comeback since Lazarus?January 31, 2025 | msn.comInvestors considering a £10,000 holding in this FTSE 250 gem could make £17,599 a year in passive income over time!January 30, 2025 | msn.comHow realistic is the 10%+ dividend yield from this FTSE 250 stock?December 27, 2024 | msn.comYielding 10.6% after a 20% decline, are abrdn shares simply too cheap to ignore?November 3, 2024 | msn.comThe abrdn share price has crashed 18% in a week, lifting the yield to a mind-blowing 10.35%!October 27, 2024 | uk.finance.yahoo.comForeigners Dump Thai Bonds as BOT Signals No Further Rate CutsOctober 24, 2024 | uk.finance.yahoo.comAbrdn Adviser COO: ‘Brand trust and equity must be earned’October 5, 2024 | moneymarketing.co.ukFixing UK’s Sewage Leaks Will Be More Costly After Thames Water MessSeptember 23, 2024 | finance.yahoo.comabrdn plc (SLFPY) Stock Price, News, Quote & History - Yahoo FinanceAugust 7, 2024 | finance.yahoo.comAbrdn Uk Small Regulatory NewsJuly 31, 2024 | lse.co.ukAbrdn Great Share ChatApril 16, 2024 | lse.co.ukabrdn plc (LON:ABDN) most popular amongst individual investors who own 52% of the shares, institutions hold 46%November 23, 2023 | finance.yahoo.comAbrdn PLC DRC (SLFPY)November 10, 2023 | uk.investing.comabrdn PLC ABDNOctober 31, 2023 | morningstar.comAbrdn Japan B Share ChatOctober 12, 2023 | lse.co.ukEven after rising 8.4% this past week, abrdn (LON:ABDN) shareholders are still down 7.6% over the past five yearsOctober 12, 2023 | finance.yahoo.comAbrdn Smaller Companies chair laments another disappointing yearAugust 28, 2023 | proactiveinvestors.co.ukMedia Sentiment Over TimeCLIGF, RPCGF, HOWWY, and SLFPY Company DescriptionsClinigen Group OTCMKTS:CLIGF$8.02 0.00 (0.00%) As of 03/24/2023Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.HOPEWELL HOLDIN/ADR OTCMKTS:HOWWY$4.80 -0.02 (-0.44%) As of 05/17/2019Hopewell Holdings Limited (HHL), the Hong Kong-based group, was listed on The Stock Exchange of Hong Kong in 1972. HHL and its subsidiaries are active in the fields of property development and investment, investment in infrastructure projects, hotel investment and management, restaurant operations and food catering.RPC Group OTCMKTS:RPCGF$10.40 0.00 (0.00%) As of 07/2/2019RPC Group Plc operates as a plastic product design and engineering company worldwide. It operates through two segments, Packaging and Non-Packaging. The Packaging segment designs plastic packaging for end markets, including the food, beverage, personal care, and healthcare markets; and designs and manufactures other plastic products, such as containers for surface coatings comprising paint pots and vaping accessories. It sells its products directly to the brands, as well as to retailers or fillers. The Non-Packaging segment designs and manufactures a range of plastic products that include temporary storage systems for waste and recycling; and technical components for the automotive and heavy vehicles industries. It also makes moulds, which are used to make plastic components and packaging products. This segment sells its products to intermediaries. The company was founded in 1991 and is headquartered in Rushden, the United Kingdom.abrdn OTCMKTS:SLFPY$10.68 0.00 (0.00%) As of 06/11/2025abrdn plc provides asset management services in the United Kingdom, Europe, North America, and Asia. The company offers investment solutions and funds; long-term savings and investment products to individual and corporate customers; and life insurance and savings products. It provides its products through institutional, wholesale, and retail distribution channels. It also makes real estate investments. The company was formerly known as Standard Life Aberdeen plc. abrdn plc was founded in 1825 and is headquartered in Edinburgh, United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alibaba’s Dip Is a Gift—Here’s the Price That Matters GameStop Turns a Profit, But Core Business Keeps Shrinking Why a Trump-Musk Feud Could Mean Big Wins for AST SpaceMobile Dave & Buster’s: Short-Covering Rally Signals Big Upside for PLAY GitLab: Buy It Low While You Still Can—Higher Prices Are Coming RKLB Breakout Fails Near Highs: Should Investors Be Concerned? Amazon Is on Track to Hit a Critical Level: Watch Out Tesla Stock: Why These 2 Downgrades Are Actually a Buy Signal Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
